IM

Immunovant

IMVT

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-405.21M

EBITDA$-381.48M

EBIT$-382.17M

Pre-tax Income$-460.56M

Net Income$-382.71M

Balance Sheet

Net Cash$9.95B

Cash Equivalent$510.75M

Total Debt$69.25K

Net Debt$-9.95B

Book Value$491.02M

Net Cash Per Share48.92

Book Value Per Share3.36

Key Ratios

Return on Equity (ROE)-58.50%

Return on Assets (ROA)-53.31%

Return on Invested Capital (ROI)-58.50%

Net Profit Marginundefined

Current Ratio11.16

Quick Ratio10.42

Long-Term Debt / Equitynull